The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 91 results:
Author [ Title(Desc)] Type Year
Filters: Author is Giannakoulas, George  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
Giannakoulas, G., & Ntiloudi D. (2017).  Acquired cardiovascular disease in adult patients with congenital heart disease. Heart. heartjnl-2017-311997.
Giannakoulas, G., & Ntiloudi D. (2018).  Acquired cardiovascular disease in adult patients with congenital heart disease.. Heart. 104(7), 546-547.
Ntiloudi, D., Giannakoulas G., Parcharidou D., Panagiotidis T., Gatzoulis M. A., & Karvounis H. (2016).  Adult congenital heart disease: A paradigm of epidemiological change.. Int J Cardiol. 218, 269-274.
Kaiafa, G., Kanellos I., Savopoulos C., Kakaletsis N., Giannakoulas G., & Hatzitolios A. I. (2015).  Is anemia a new cardiovascular risk factor?. Int J Cardiol. 186, 117-24.
Kokkinidis, D. G., Zareifopoulos N., Theochari C. A., Arfaras-Melainis A., Papanastasiou C. A., Uppal D., et al. (2020).  Association Between Atrial Fibrillation and Cognitive Impairment in Individuals With Prior Stroke: A Meta-Analysis and Meta-Regression Analysis.. Stroke. 51(6), 1662-1666.
Giannakoulas, G., Savvoulidis P., Grosomanidis V., Mouratoglou S-A., Karvounis H., & Hadjimiltiades S. (2016).  Atrial septostomy and disease targeting therapy in pulmonary hypertension secondary to neurofibromatosis.. BMC Pulm Med. 16(1), 175.
B
Arvanitaki, A., Giannakoulas G., Mouratoglou S. Anastasia, Feloukidis C., Karvounis H., & Hadjimiltiades S. (2018).  Balloon atrial septostomy in severe precapillary pulmonary hypertension: A single-center experience.. Hellenic J Cardiol.
Kamperidis, V., Hadjimiltiades S., Ziakas A., Sianos G., Kazinakis G., Giannakoulas G., et al. (2015).  Balloon valvuloplasty as destination therapy in elderly with severe aortic stenosis: a cardiac catheterization study.. J Geriatr Cardiol. 12(3), 218-25.
Tzeis, S., Tsiachris D., Asvestas D., Kourouklis S., Patsourakos F., Karlis D., et al. (2020).  Beneficial Effect of Flecainide Controlled Release on the Quality of Life of Patients with Atrial Fibrillation-the REFLEC-CR Study.. Cardiovasc Drugs Ther. 34(3), 383-389.
Vlachou, M., Kamperidis V., Giannakoulas G., Karamitsos T., Vlachaki E., & Karvounis H. (2020).  Biochemical and imaging markers in patients with thalassaemia.. Hellenic J Cardiol.
Giannakoulas, G., Mouratoglou S-A., Gatzoulis M. A., & Karvounis H. (2014).  Blood biomarkers and their potential role in pulmonary arterial hypertension associated with congenital heart disease. a systematic review.. Int J Cardiol. 174(3), 618-23.
Giannakoulas, G., Mouratoglou S. Anastasia, & Karvounis H. (2015).  B-type natriuretic peptide: another brick in the wall towards better risk stratification in repaired tetralogy of Fallot.. Heart. 101(6), 416-7.
Dimitroulas, T., Giannakoulas G., Karvounis H., Garyfallos A., Settas L., & Kitas G. (2012).  B-type natriuretic peptide in rheumatic diseases: a cardiac biomarker or a sophisticated acute phase reactant?. Autoimmun Rev. 11(12), 837-43.
C
Sianos, G., Giannakoulas G., Konstantinidis N. V., Mouratoglou S. Anastasia, Koletas V., Sofidis G., et al. (2016).  A case of balloon pulmonary angioplasty as a palliative therapy in chronic thromboembolic pulmonary hypertension.. Hellenic J Cardiol. 57(5), 363-365.
Bazmpani, M. Anna, Arsos G., Zarogoulidis P., Doumas A., Dimitroulas T., Sianos G., et al. (2018).  A case of sarcoidosis-associated pulmonary hypertension masquerading as chronic thromboembolic pulmonary hypertension. Pulmonary Circulation. 85733(3), 204589401876828.
Bazmpani, M. Anna, Arsos G., Zarogoulidis P., Doumas A., Dimitroulas T., Sianos G., et al. (2018).  A case of sarcoidosis-associated pulmonary hypertension masquerading as chronic thromboembolic pulmonary hypertension.. Pulm Circ. 8(3), 2045894018768289.
Tsakiridis, I., Giouleka S., Arvanitaki A., Mamopoulos A., Giannakoulas G., Papazisis G., et al. (2021).  Chronic hypertension in pregnancy: synthesis of influential guidelines.. J Perinat Med. 49(7), 859-872.
Gourzoulidis, G., Kourlaba G., Kakisis J., Matsagkas M., Giannakoulas G., Gourgoulianis K. I., et al. (2017).  Cost-Effectiveness Analysis of Rivaroxaban for Treatment of Deep Vein Thrombosis and Pulmonary Embolism in Greece. Clinical Drug Investigation. 3720113350142914930161243078363366301713154614171321391617731648921111413285823092141331041430113112173333(98221823311234261451031644210713311062365432454625101839), 833 - 844.
D
Dimopoulos, K., Diller G-P., Opotowsky A. R., D'Alto M., Gu H., Giannakoulas G., et al. (2018).  Definition and Management of Segmental Pulmonary Hypertension.. J Am Heart Assoc. 7(14), 
Konstantinou, D. M., Papadopoulou K., Giannakoulas G., Kamperidis V., Dalamanga E. G., Damvopoulou E., et al. (2014).  Determinants of functional mitral regurgitation severity in patients with ischemic cardiomyopathy versus nonischemic dilated cardiomyopathy.. Echocardiography. 31(1), 21-8.
Konstantinou, D. M., Karvounis H., & Giannakoulas G. (2016).  Digoxin in Heart Failure with a Reduced Ejection Fraction: A Risk Factor or a Risk Marker.. Cardiology. 134(3), 311-9.
Farmakis, D., Davlouros P., Giamouzis G., Giannakoulas G., Pipilis A., Tsivgoulis G., et al. (2018).  Direct Oral Anticoagulants in Nonvalvular Atrial Fibrillation: Practical Considerations on the Choice of Agent and Dosing.. Cardiology. 140(2), 126-132.
Mouratoglou, S. Anastasia, Kallifatidis A., Pitsiou G., Grosomanidis V., Kamperidis V., Chalikias G., et al. (2020).  Duration of interventricular septal shift toward the left ventricle is associated with poor clinical outcome in precapillary pulmonary hypertension: A cardiac magnetic resonance study.. Hellenic J Cardiol. 61(2), 112-117.
E
D'Alto, M., Constantine A., Balint O. Hajnalka, Romeo E., Argiento P., Ablonczy L., et al. (2019).  The effects of parenteral prostacyclin therapy as add-on treatment to oral compounds in Eisenmenger syndrome.. Eur Respir J. 54(5), 
Arvanitaki, A., Giannakoulas G., Baumgartner H., & Lammers A. Elisabeth (2020).  Eisenmenger syndrome: diagnosis, prognosis and clinical management.. Heart. 106(21), 1638-1645.

Pages

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.